Member Tool: Impact Assessment for Inhalers
Did you know that 100 Metered Dose Inhaler (MDI) doses are equivalent to a 130 km car journey?
MDIs are common medical devices used to deliver inhaled medication, typically used in the treatment of asthma and chronic obstructive pulmonary disease.
Choosing Wisely Canada proposes five things healthcare practitioners can do to help curb MDI-related emissions to decrease greenhouse gases.
- Does your patient actually need an inhaler? Visit Choosing Wisely Canada for more information.
- Is my patient getting the right inhaler? The right dose? The right delivery mechanism?
- Review your patient’s technique in using the inhaler.
- Remind your patient to return the inhalers to a pharmacy for safe disposal.
- Explore alternatives to MDIs, as they have a much higher carbon footprint than that of Dry Powder Inhalers.
In our continued commitment to sustainability in healthcare, this Earth Day, HealthPRO is excited to share our proprietary sustainability tool to help you track, measure and compare inhaler usage at your hospital.
Our new Impact Assessment Tool For Inhalers will help you record your current inhaler usage and its carbon footprint. Then you can select and compare alternative inhaler options to see the carbon footprint and related costs associated with them. This tool will help you report and measure your current environmental impact and help you make informed sustainable decisions for your hospital, for the health of your patients and our planet. If you are interested in learning more, contact Alicia Martin at AMartin@HealthPROCanada.com